What Feline Injection-Site Sarcoma Is
Feline injection-site sarcoma, often abbreviated FISS, is a malignant soft-tissue sarcoma that arises at sites where injections — most commonly vaccines, but also long-acting antibiotics, steroid injections, and microchips in rare cases — were previously administered. The most common cell type is fibrosarcoma, but related tumors such as malignant fibrous histiocytoma and rhabdomyosarcoma are sometimes seen at the same sites. Whatever the precise cellular subtype, the behavior is similar: locally aggressive, deeply invasive, prone to recurrence, with relatively low but real metastatic potential to the lungs.
In this article
- What Feline Injection-Site Sarcoma Is
- The 3-2-1 Rule Every Cat Owner Should Know
- Why Vaccines Are Still Recommended
- Recognizing FISS Versus a Benign Vaccine Reaction
- How Veterinarians Diagnose FISS
- Why Surgery Has to Be So Aggressive
- Radiation Therapy as Adjunctive Treatment
- Chemotherapy and Newer Approaches
- Prognosis Without Inventing Numbers
- Pain Management and Quality of Life
- Prevention and Smart Vaccination Practices
- Cost, Insurance, and Specialist Referral
- Frequently Asked Questions
This is one of the most studied cancers in feline medicine because it is iatrogenic — caused, at least in part, by something we do to cats deliberately. The estimated incidence is roughly one case per one thousand to one per ten thousand vaccinations, and the absolute risk per dose remains low. Still, every owner of a vaccinated cat should know the warning signs and the simple rule that catches these tumors early.
The 3-2-1 Rule Every Cat Owner Should Know
The single most important piece of information in this article is a simple early-warning rule. Any lump at a vaccination site that meets any one of the following three criteria warrants immediate biopsy:
- 3 — present more than three months after the injection
- 2 — larger than two centimeters in diameter
- 1 — growing in size one month after the injection
If a post-vaccination lump meets any of those, call your vet and request an incisional biopsy or wedge biopsy. Do not wait. Do not aspirate-and-watch. The reason is that fine needle aspiration cannot reliably distinguish a benign granuloma from an early sarcoma, and every week of delay makes the surgical cure harder. The 3-2-1 rule is a tripwire that catches FISS while it is still potentially curable.
Why Vaccines Are Still Recommended
Despite the existence of FISS, core feline vaccines (rabies, FVRCP) remain strongly recommended. The diseases they prevent — rabies, panleukopenia, severe upper respiratory viral disease — kill far more cats than FISS. Modern guidance from feline medicine specialists addresses the risk by changing how and where vaccines are given, not by stopping them. The American Association of Feline Practitioners has updated guidelines for vaccination location and schedule that most modern veterinarians follow.
Modern injection sites for cats are deliberately distal — leg vaccinations rather than the classic interscapular (between the shoulder blades) site. The reasoning is brutal but practical: a sarcoma that develops on a leg is theoretically amputable, while one between the shoulder blades is anatomically far harder to remove with adequate margins. This is one of the most important changes in feline preventive medicine in the past two decades.
Recognizing FISS Versus a Benign Vaccine Reaction
A small lump at a vaccine site within a few days to a few weeks is common and almost always a benign post-vaccinal granuloma — a localized inflammatory reaction that resolves on its own. These benign lumps are typically small (well under two centimeters), non-tender or mildly tender, and shrink steadily over weeks. They should be gone or nearly gone by three months.
FISS lumps behave differently. They grow rather than shrink. They become firmer rather than softer. They may seem fixed to deeper tissue rather than moving freely under the skin. They cross the three-month timeline still present, often larger than they were initially. Any post-vaccination lump that fails the 3-2-1 rule is a sarcoma until proven otherwise by biopsy.
How Veterinarians Diagnose FISS
Diagnosis begins with a thorough history (when and where did the cat last receive any injection?) and physical exam, including measurement of the lump and assessment of mobility. The next step is biopsy — incisional or wedge biopsy, never excisional biopsy at this stage. The reason is that a small “just remove it” excision contaminates the surgical field and makes the eventual definitive surgery much harder if the lump turns out to be FISS. Biopsy first, definitive surgery second.
Once histopathology confirms FISS, staging follows: three-view chest radiographs to look for pulmonary metastasis, complete blood work, and either contrast CT scan or MRI of the affected region to map the true extent of the tumor. CT or MRI of the tumor region is essential for surgical planning because FISS tumors send out invisible-to-the-eye projections of cells along fascial planes; the visible mass is just the tip of the iceberg. CT scans for staging in cats commonly run fifteen hundred to three thousand dollars depending on region.
Our companion article on cat injection-site sarcoma covers some of this from a slightly different angle.
Why Surgery Has to Be So Aggressive
FISS is one of the most surgically demanding cancers in small animal oncology. Adequate excision typically requires three to five centimeter margins of normal-appearing tissue in every direction, including down to and through one fascial plane below the tumor. Translated into practical terms, that often means removing chunks of muscle, fascia, and even portions of bone or vertebral spinous processes if the tumor is in the classic interscapular location. Limb tumors may require amputation. Body-wall tumors may require body-wall reconstruction with mesh.
This is not surgery for a general practice. FISS surgery is best performed by a board-certified veterinary surgeon (ACVS) or a surgical oncologist, ideally working with a radiation oncologist and medical oncologist on the same team. Half-measures don’t work; an incompletely excised FISS recurs in months, and each recurrence is harder to manage than the last. This is the cancer where doing the big surgery first matters most.
Radiation Therapy as Adjunctive Treatment
Most cats with FISS benefit from adjunctive radiation therapy in addition to surgery. Radiation can be given before surgery (neoadjuvant) to shrink the tumor and create cleaner surgical planes, or after surgery (adjuvant) to clean up microscopic disease at the surgical margins. The protocol typically involves a series of treatments over several weeks at a referral center with a linear accelerator.
For tumors with incomplete margins, radiation dramatically reduces local recurrence rates and is often the difference between long-term control and inevitable recurrence. Decisions about radiation timing and protocol are made by a board-certified radiation oncologist (ACVR-Radiation Oncology) in consultation with the surgical and medical oncology team.
Chemotherapy and Newer Approaches
Chemotherapy plays a smaller role in FISS than in some other feline cancers but is sometimes recommended for incompletely excised tumors, high-grade tumors, or tumors with vascular invasion. Doxorubicin-based protocols are the most common. Newer approaches under active study include electrochemotherapy, intratumoral immunotherapy, and various tyrosine kinase inhibitors.
Treatment decisions in FISS are best directed by a board-certified veterinary oncologist (ACVIM-Oncology). Ask your primary vet for a referral the moment biopsy confirms the diagnosis. For broader feline cancer context, see our overview of cancer in cats.
Prognosis Without Inventing Numbers
Prognosis varies widely and depends most strongly on whether the first surgery achieved complete margins, whether radiation was added, the histologic grade, and the tumor location. Cats whose tumors are completely excised at the first surgery and who receive appropriate adjuvant radiation often achieve durable local control. Cats whose tumors recur after incomplete first surgery have a more guarded outlook, with each recurrence shrinking the surgical options available.
Distant metastasis, most commonly to the lungs, occurs in a meaningful minority of cases but is not the most common cause of death in this disease. Local recurrence, with progressive invasion into structures that cannot be removed, is the more common endpoint. This makes the first surgery the single most important treatment decision a family will make.
Pain Management and Quality of Life
Surgery for FISS is significant and recovery takes weeks. Pain is managed with a combination approach: opioid coverage in hospital, transitioning to oral non-steroidal coverage with Onsior and gabapentin at home for typically two to three weeks. Wound care, e-collar use, and restricted activity are essential during healing. Drains may be in place for the first several days after large excisions.
For families navigating advanced or recurrent disease, hospice care focused on pain control, hydration, nutrition, and quiet time at home is a valid path. The ASPCA Pet Loss hotline at 877-474-3310 supports families through end-of-life decisions, and your oncologist can connect you with a hospice-focused veterinarian if appropriate.
Prevention and Smart Vaccination Practices
FISS cannot be eliminated as a risk, but it can be reduced. Smart practices include vaccinating in distal limb sites rather than between the shoulder blades, recording exact location of every injection in the medical record, choosing non-adjuvanted feline vaccines where available, spacing non-essential vaccinations rather than giving multiple injections in one visit, and always following the 3-2-1 rule for any post-injection lump.
Discuss with your veterinarian whether your individual cat needs every vaccine on the standard schedule. A strictly indoor cat with low exposure risk may have a tailored vaccination plan that reduces total injections. The goal is appropriate protection from infectious disease, not zero injections — and the modern feline-medicine framework gives owners the tools to balance both risks thoughtfully.
Cost, Insurance, and Specialist Referral
FISS is an expensive disease to treat correctly. CT or MRI staging runs into the low thousands. Definitive surgery at a referral hospital, with histopathology and pre-and-post-operative care, typically falls in the several-thousand-dollar range. Radiation protocols add several thousand more. Pet insurance, if purchased before symptoms appear, often covers a substantial portion. Ask your primary vet about cost ranges in your area, and explore veterinary specialist cost options.
Frequently Asked Questions
Should I stop vaccinating my cat to prevent FISS?
No. The diseases prevented by core feline vaccines kill far more cats than FISS. Modern injection-site practices and tailored vaccination schedules reduce risk while maintaining protection. Discuss the right plan for your individual cat with your veterinarian.
How long after a vaccine is a lump considered abnormal?
Use the 3-2-1 rule: any lump that is present more than three months after injection, larger than two centimeters, or growing one month after injection should be biopsied promptly.
Can my regular vet remove a FISS, or do I need a specialist?
FISS surgery is best done by a board-certified veterinary surgeon (ACVS), often in coordination with radiation and medical oncology. The first surgery is the single most important treatment decision; do it right with the right team.
Will my cat lose a leg?
Limb amputation is sometimes recommended for FISS on a limb because amputation is curative for many limb tumors and avoids the risk of incomplete excision. Cats adapt to three legs astonishingly well, and tripod cats live full active lives.
Is FISS contagious to my other cats?
No. FISS is not infectious. It develops in individual cats in response to local tissue inflammation at injection sites and cannot be transmitted between cats.